Takeda Receives Complete Response Letter From FDA For Alogliptin, ACTOS
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
Internet Safety
 
 
Takeda Receives Complete Response Letter From FDA For Alogliptin, ACTOS
4 Sep 09, 14:55
Containing long-term survival data for Velcade for injection ... FDA requests additional CV safety trial ...
more

 

 
© 2007 nafdacnigeria.org